M
Mirova Portfolio holdings
AUM
$709M
This Quarter Return
+1.28%
1 Year Return
+10.96%
3 Year Return
+44.1%
5 Year Return
+108.38%
10 Year Return
–
AUM
$568M
AUM Growth
-$125M
(-18%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-23.03%
Top 10 Holdings %
Top 10 Hldgs %
61.62%
Holding
166
New
2
Increased
26
Reduced
133
Closed
3
Top Buys
| 1 |
Enphase Energy
ENPH
|
$8.19M |
| 2 |
Accenture
ACN
|
$2.21M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$1.94M |
| 4 |
CGI
GIB
|
$1.22M |
| 5 |
Estee Lauder
EL
|
$1.2M |
Top Sells
| 1 |
Ecolab
ECL
|
$41.8M |
| 2 |
Thermo Fisher Scientific
TMO
|
$22.8M |
| 3 |
NVIDIA
NVDA
|
$6.77M |
| 4 |
Microsoft
MSFT
|
$3.6M |
| 5 |
eBay
EBAY
|
$2.24M |
Sector Composition
| 1 | Technology | 40.37% |
| 2 | Healthcare | 26.5% |
| 3 | Industrials | 8.12% |
| 4 | Materials | 7.88% |
| 5 | Utilities | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Public Service Enterprise Group
PEG
$40.9B
| $392K | 0.07% |
6,253
-7,790
| -55% | -$488K |
|
102
HCA Healthcare
HCA
$95.7B
| $374K | 0.07% |
1,231
-1,340
| -52% | -$407K |
|
103
American Tower
AMT
$92.2B
| $364K | 0.06% |
1,875
-775
| -29% | -$150K |
|
104
Edwards Lifesciences
EW
$47.5B
| $341K | 0.06% |
3,611
-4,045
| -53% | -$382K |
|
105
Amgen
AMGN
$152B
| $331K | 0.06% |
1,492
-1,851
| -55% | -$411K |
|
106
Sensient Technologies
SXT
$4.81B
| $330K | 0.06% |
4,635
+627
| +16% | +$44.6K |
|
107
Sun Life Financial
SLF
$32.7B
| $321K | 0.06% |
6,152
-2,540
| -29% | -$133K |
|
108
Aflac
AFL
$57.5B
| $308K | 0.05% |
4,407
-5,375
| -55% | -$375K |
|
109
Humana
HUM
$37.4B
| $304K | 0.05% |
679
-739
| -52% | -$330K |
|
110
Canadian Pacific Kansas City
CP
$70.1B
| $300K | 0.05% |
3,710
-1,503
| -29% | -$121K |
|
111
Canadian National Railway
CNI
$60.1B
| $300K | 0.05% |
2,474
-1,022
| -29% | -$124K |
|
112
Eastman Chemical
EMN
$7.7B
| $291K | 0.05% |
3,481
+771
| +28% | +$64.5K |
|
113
DexCom
DXCM
$31.1B
| $288K | 0.05% |
2,240
-2,438
| -52% | -$313K |
|
114
Telus
TU
$25.3B
| $276K | 0.05% |
14,170
-5,850
| -29% | -$114K |
|
115
Moderna
MRNA
$9.21B
| $250K | 0.04% |
2,059
-2,212
| -52% | -$269K |
|
|
STKL
116
SunOpta
STKL
$741M
| $246K | 0.04% |
36,735
+11,797
| +47% | +$78.9K |
|
117
Biogen
BIIB
$20.6B
| $239K | 0.04% |
838
-853
| -50% | -$243K |
|
118
Conagra Brands
CAG
$9.17B
| $236K | 0.04% |
+7,000
| New | +$236K |
|
119
Centene
CNC
$14.1B
| $214K | 0.04% |
3,176
-3,550
| -53% | -$239K |
|
120
Fortinet
FTNT
$58B
| $203K | 0.04% |
2,681
-4,459
| -62% | -$337K |
|
121
Sweetgreen
SG
$1.04B
| $193K | 0.03% |
15,054
+737
| +5% | +$9.45K |
|
122
ResMed
RMD
$39.2B
| $185K | 0.03% |
845
-896
| -51% | -$196K |
|
123
Roper Technologies
ROP
$56.2B
| $179K | 0.03% |
372
-610
| -62% | -$293K |
|
124
Becton Dickinson
BDX
$54.2B
| $178K | 0.03% |
676
-1,130
| -63% | -$298K |
|
125
Boston Scientific
BSX
$159B
| $177K | 0.03% |
3,269
-5,431
| -62% | -$294K |
|